rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chan Henry Lee

SVP, General Counsel

Company insider

Files Form 4 as: SVP, General Counsel, BeOne Medicines.

In numbers

Trades disclosed
204
Buys
0
Sells
28
Bought
$0
Sold
$20.5M
Companies
1
Companies where not an officer
0
First trade
15 Jun 2023
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
ONC BeOne MedicinesOfficer · Biotechnology · last 30 Sep 20260 buys · 28 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$418K1,115 at $375.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$158K812 at $194.47filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$226K1,058 at $213.32filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$127K796 at $159.03filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,556 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—13,754 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,348 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$960K2,666 at $360.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,556 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—13,754 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code M—10,348 at $0.00filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$158K812 at $194.47filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$226K1,058 at $213.32filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$127K796 at $159.03filing
11 Aug 2026filed 13 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$960K2,666 at $360.00filing
30 Jul 2026filed 3 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$338K1,044 at $323.69filing
30 Jul 2026filed 3 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$338K1,044 at $323.69filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$100K514 at $194.47filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$142K665 at $213.32filing
22 Jul 2026filed 24 Jul 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code M$78K490 at $159.03filing

News

BeOne Medicines (NASDAQ:ONC) Stock: Insider Chan Henry Lee Sells 1,115 Sharesthemarketsdaily.com · 2 Oct 2026Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026

1 headline in the last 90 days name Chan Henry Lee; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care28

Buys in green, sells in red, by the company’s sector.

Related people

Xiaodong WangDirector and Other role · Director and Other at BeOne Medicines, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Director at BeOne Medicines, filing Form 4 there in the last year
Titus B. BallPrincipal Accounting Officer · Principal Accounting Officer at BeOne Medicines, filing Form 4 there in the last year
Xiaobin WuPresident and COO · President and COO at BeOne Medicines, filing Form 4 there in the last year
John OylerChief Executive Officer · Chief Executive Officer at BeOne Medicines, filing Form 4 there in the last year
Aaron RosenbergChief Financial Officer · Also traded ONC in the last 90 days